Study identity card

CHARISMA

United Kingdom
Share
  • Disease: COVID-19, Influenza
  • Study type: Observational Cohort Study, Natural History
  • Study type descriptors: Prospective, Single centre
  • Objective: To characterise influenza and SARS-CoV-2-associated severe acute respiratory illness (SARI) using a novel enhanced syndromic surveillance system during the 2021/2022 winter season
  • Number of participants enrolled: 1037
  • Study enrolling from to
  • Study includes follow-up for 28 days
  • Standardisation: ICD-10

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Influenza virus
  • Influenza-like illness/Acute respiratory infection
  • Blood sample
  • Nasopharyngeal swab

Other information

Funders/Sponsors:

  • https://ror.org/023wh8b50

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to